U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H15N3O5
Molecular Weight 257.2432
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 5-METHYLCYTIDINE

SMILES

CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N=C1N

InChI

InChIKey=ZAYHVCMSTBRABG-JXOAFFINSA-N
InChI=1S/C10H15N3O5/c1-4-2-13(10(17)12-8(4)11)9-7(16)6(15)5(3-14)18-9/h2,5-7,9,14-16H,3H2,1H3,(H2,11,12,17)/t5-,6-,7-,9-/m1/s1

HIDE SMILES / InChI

Molecular Formula C10H15N3O5
Molecular Weight 257.2432
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

5-methyl cytidine has been indicated in the controlling mechanism for the genetic change, which leads to cancer. Human APOBEC3A (A3A), a polynucleotide cytidine deaminase (PCD) with specificity for single stranded DNA, can extensively deaminate human nuclear DNA. It was discovered that A3A among all human PCDs can deaminate 5-methylcytidine in a variety of single stranded DNA substrates both in vitro and in transfected cells almost as efficiently as cytidine itself. As 5MeCpG deamination hotspots characterize many genes associated with cancer it was made suggestion that A3A is a major player in the onset of cancer.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P31941
Gene ID: 100913187|||200315
Gene Symbol: APOBEC3A
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Inhibition of urethan induced lung tumour growth in strain A mice by 5-methyl cytidine.
1980
The nature of cancer and the mechanisms of its control: a review.
1980
Immunochemical detection of urinary 5-methyl-2'-deoxycytidine as a potential biologic marker for leukemia.
1995 Jan 31
Synthesis of novel 3'-C-methylene thymidine and 5-methyluridine/cytidine H-phosphonates and phosphonamidites for new backbone modification of oligonucleotides.
2001 Apr 20
Measurement of genome wide DNA methylation by reversed-phase high-performance liquid chromatography.
2002 Jun
Distinct nuclear organization, DNA methylation pattern and cytokinin distribution mark juvenile, juvenile-like and adult vegetative apical meristems in peach (Prunus persica (L.) Batsch).
2002 May
The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide.
2004 Aug
Kilo-scale synthesis process for 2'-O-(2-methoxyethyl)-pyrimidine derivatives.
2005
Modifications in small interfering RNA that separate immunostimulation from RNA interference.
2008 Mar 1
Effective, homogeneous and transient interference with cytosine methylation in plant genomic DNA by zebularine.
2009 Feb
Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD).
2009 Jul
DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis.
2009 Jul 23
Effect of IVF and laser zona dissection on DNA methylation pattern of mouse zygotes.
2009 Sep-Oct
Multi-site-specific 16S rRNA methyltransferase RsmF from Thermus thermophilus.
2010 Aug
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Curator's Comment: As several TP53 CpG methylation sites are mutational hotspots in cancer, an oligodeoxynucleotide corresponding to part of exon 8 was synthesized with 5-methylcytidine (5MeC) incorporated at two known sites of methylation in codons 273 and 282. Following incubation with purified myc-His6-tagged A3A (human APOBEC3A (A3A), a polynucleotide cytidine deaminase (PCD)) and recovery of products by standard PCR, both 5MeC and C were readily deaminated in a comparable manner. Given that 5MeC is deaminated by A3A the singularity of 5MeCpG mutation hotspots in cancer probably has more to do with the relative efficiency of T:G mismatch repair compared to highly efficient U:G repair initiated by UNG.
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 09:45:07 GMT 2023
Edited
by admin
on Sat Dec 16 09:45:07 GMT 2023
Record UNII
TL9PB228DC
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
5-METHYLCYTIDINE
Systematic Name English
4-AMINO-1-.BETA.-D-ARABINOFURANOSYL-5-METHYLPYRIMIDIN-2(1H)-ONE
Systematic Name English
5-METHYL-CYTIDINE
Systematic Name English
NSC-363933
Code English
CYTARABINE IMPURITY I [EP IMPURITY]
Common Name English
CYTIDINE, 5-METHYL-
Systematic Name English
Code System Code Type Description
NSC
363933
Created by admin on Sat Dec 16 09:45:07 GMT 2023 , Edited by admin on Sat Dec 16 09:45:07 GMT 2023
PRIMARY
PUBCHEM
92918
Created by admin on Sat Dec 16 09:45:07 GMT 2023 , Edited by admin on Sat Dec 16 09:45:07 GMT 2023
PRIMARY
CAS
2140-61-6
Created by admin on Sat Dec 16 09:45:07 GMT 2023 , Edited by admin on Sat Dec 16 09:45:07 GMT 2023
PRIMARY
EPA CompTox
DTXSID401016977
Created by admin on Sat Dec 16 09:45:07 GMT 2023 , Edited by admin on Sat Dec 16 09:45:07 GMT 2023
PRIMARY
WIKIPEDIA
5-Methylcytidine
Created by admin on Sat Dec 16 09:45:07 GMT 2023 , Edited by admin on Sat Dec 16 09:45:07 GMT 2023
PRIMARY
FDA UNII
TL9PB228DC
Created by admin on Sat Dec 16 09:45:07 GMT 2023 , Edited by admin on Sat Dec 16 09:45:07 GMT 2023
PRIMARY
ECHA (EC/EINECS)
218-390-8
Created by admin on Sat Dec 16 09:45:07 GMT 2023 , Edited by admin on Sat Dec 16 09:45:07 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> IMPURITY